Genetics

Mimicking effect of exercise with gene therapy

It sounds too good to be true—and it is. But Jose Bianco Moreira and the CERG research group at NTNU are convinced that some of the positive health effects of physical exercise can be achieved using gene therapy and medication.

Diseases, Conditions, Syndromes

US scientists developing nasal spray to prevent COVID-19

Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.

Neuroscience

Childhood dementia: Insights from the eyes

Is the eye a window to the brain in Sanfilippo syndrome, an untreatable form of childhood-onset dementia, Australian researchers ask in a new publication.

Oncology & Cancer

New therapy to target the spread of bowel cancer

For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to help people with metastatic bowel cancer.

Neuroscience

Scientists develop new gene therapy for eye disease

Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the ...

Medical research

A gene mutation that protects against disease

Canadian scientists looking at a rare genetic mutation think they may have discovered the proverbial fountain of youth. But it's not for everyone: so far, the mutation has only been found in a handful of French-Canadian families.

Genetics

Gene therapy startup to increase AAV gene therapy efficiency

Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH). The NIH Platform Vector Gene Therapy (PaVe-GT) project ...

Genetics

Risk of AAV mobilization in gene therapy

New data highlight safety concerns for the replication of recombinant adeno-associated viral (rAAV) vectors commonly used in gene therapy. These findings, which emphasize the need for mobilization resistant AAV vectors, are ...

page 1 from 40